- Researchers have developed a risk calculator that estimates the risk of kidney failure after donation.
- Overall risk was quite low, but black race and male sex were associated with increased risks of developing kidney failure in living kidney donors.
- Older age was associated with greater kidney failure risk in nonblack donors, but not in in black donors.
- Higher body mass index and a close biological relationship to the transplant recipient were also associated with increased risks of kidney failure.
Washington, DC (April 27, 2017) -- Researchers have developed a risk calculator to provide personalized risk estimates of developing kidney failure after donation. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN), may be useful for individuals considering donation, for living donors wishing to understand their long-term risk, and for clinicians who monitor the long-term health of living donors.
Research suggests that there are minimal health consequences for individuals who selflessly donate a kidney, but only a few comprehensive studies have looked at this issue. Also, although long-term studies of living kidney donors have reported low rates of premature death and kidney failure, personalized estimates based on donor characteristics have not previously been available.
To help provide accurate estimates of long-term risks, a team led by Dorry Segev, MD, PhD, of the Johns Hopkins University School of Medicine and the Johns Hopkins School of Public Health, studied information on 133,824 living kidney donors from 1987 to 2015, as reported to the Organ Procurement and Transplantation Network.
Overall risk was quite low: the investigators predicted that the median risk of kidney failure was only 1 case per 10,000 donors at 5 years after donation and only 34 per 10,000 donors at 20 years after donation. Nevertheless, black race and male sex were associated with 3.0- and 3.9-times increased risks of developing kidney failure, respectively. Among nonblack donors, older age was linked with greater risk, but this was not seen in black donors. Higher body mass index was also associated with an increased risk of kidney failure.
The findings suggest that greater permissiveness may be warranted in older black candidate donors, and that young black candidates should be evaluated carefully.
"Because living kidney donors voluntarily undergo surgery for no direct medical benefit to themselves, it is incumbent upon the transplant community to provide them with accurate estimates of long-term risk," said Dr. Segev. "Our risk prediction model may be helpful to individuals considering donation, and to living donors and their care providers as they plan long-term follow-up care and health maintenance," added lead author Allan Massie, PhD, MHS.
Study co-authors include Abimereki Muzaale, MD, MPH, Xun Luo, MD, MPH, Eric Chow, MS, Jayme Locke MD, Anh Nguyen, BA, Macey Henderson, JD, PhD, Jon Snyder, PhD.
Disclosures: The authors reported no financial disclosures.
The article, entitled "Quantifying post-donation risk of ESRD in living kidney donors," will appear online at http://jasn.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has nearly 17,000 members representing 112 countries. For more information, please visit http://www.